Stone House Investment Management, LLC Recursion Pharmaceuticals, Inc. Transaction History
Stone House Investment Management, LLC
- $477 Million
- Q3 2024
A detailed history of Stone House Investment Management, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Stone House Investment Management, LLC holds 1,000 shares of RXRX stock, worth $7,570. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$7,570
Previous $7,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RXRX
# of Institutions
287Shares Held
242MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$248 Million2.05% of portfolio
-
Baillie Gifford & CO25.2MShares$191 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$184 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$131 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$116 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.37B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...